KK
Kaken Pharmaceutical Co., Ltd.
KKPCF · OTC
$26.78 +3.00% (+$0.78)
Market Cap ¥153.7B
P/E Ratio 14.98x
Div. Yield 4.77%
ROE 6.91%
Bulios Fair Price
$30.27
13.0% upside
Current Price
$26.78
Undervalued Fair Value Overvalued
According to Bulios Fair Price, KKPCF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
93 /100
Cheap EV/EBITDA 6.83x
P/S 1.74x
P/B 1.01x
Growth
70 /100
Growing Rev. growth 7.34%
FCF growth 36.06%
Book val. growth 3.48%
Profitability
51 /100
Moderate Net margin 11.62%
Op. margin 11.21%
FCF margin 0.00%
Quality
32 /100
Poor ROE 6.91%
ROA 5.52%
Asset turnover 0.47x
Debt
100 /100
Low Current ratio 4.18x
Int. coverage 223.24x
Net debt/EBITDA -3.65x
Stability
40 /100
Moderate Rev. volatility 19.20%
EPS volatility 60.07%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about KKPCF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Hiroyuki Horiuchi
Employees
1,114
Headquarters
Tokyo
Upcoming events
29 SEP
Ex-Dividend
Ex-dividend date
29 SEP
Dividend Payment
Payment date
05 NOV
Earnings
Upcoming earnings report
30 MAR
Ex-Dividend
Ex-dividend date
30 MAR
Dividend Payment
Payment date